This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
APO-Verap SR (2015-05-19)
- Starting date:
- May 19, 2015
- Posting date:
- May 21, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-53499
Recalled products
- APO-Verap SR 180 mg
Reason
Out of Specification result for dissolution testing.
Depth of distribution
Wholesalers
Affected products
A. APO-Verap SR 180 mg
DIN, NPN, DIN-HIM
DIN 02246894
Dosage form
Tablet (Extended-Release)
Strength
- Verapamil hydrochloride 180 mg
Lot or serial number
- MC 9090
Companies
- Recalling Firm
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
- Marketing Authorization Holder
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Related AWRs